• Zebrafish Tumor Models
  • Zebrafish Ocular Disease Models
  • Zebrafish Cardiovascular Disease Models
  • Zebrafish Neurological Disorder Models
  • Zebrafish Infectious Disease Models
  • Zebrafish Metabolic Disease Models
  • Zebrafish Liver Disease Models
  • Zebrafish Kidney Disease Models
  • Zebrafish Hematological Disease Models
  • Zebrafish Inflammation Disease Models
  • Zebrafish Skeletal Disease Models
  • Zebrafish Regeneration Models
  • Zebrafish Hearing-Related Disease Models
  • Zebrafish Obesity Models

    Zebrafish Obesity Models

    Obesity is a major risk factor for diabetes, cardiovascular disease, cancer, sleep apnea, nonalcoholic fatty liver disease, osteoarthritis, and other diseases, and is associated with disability, mortality, and health costs. Therefore, excellent animal models of obesity are essential to better understand the development of metabolic dysfunction and the development of anti-obesity drugs.

    Multiple studies have demonstrated that zebrafish are an excellent model for studying metabolic dysfunction, as zebrafish possess key organs important for regulating energy homeostasis and metabolism in mammals, including digestive organs, adipose tissue, and skeletal muscle. Similar to mammals, excess nutrients in zebrafish lead to elevated plasma triglyceride levels and hepatic steatosis. The highly conserved distribution and formation of adipose tissue in zebrafish compared to mammals makes it a suitable model for studying obesity. Obese zebrafish also exhibit dysregulation of pathways that control lipid metabolism, including SREBF1, PPAR, NR1H3, and LEP. These metabolic pathways play key roles in adipocyte differentiation, energy homeostasis, and cholesterol metabolism, and their protection proves that zebrafish is a suitable model for human lipid metabolism.

    3D micro-CT analysis of normally-fed and obese-fed zebrafish.3D micro-CT analysis of normally-fed and obese-fed zebrafish.

    Our Zebrafish Obesity Models

    • Food-induced zebrafish obesity models
    TreatmentZebrafish AgeCharacteristics
    Heavy whipping creamLarvaeLipid accumulation in intersegmental vessels; increased whole-larval triacylglycerol (TAG) and apolipoprotein B levels
    Chicken egg yolkLarvae, juvenile, adultHyperlipidemia, increased adipose tissue area and TAG
    Corn oil and lardAdultIncreased body fat
    ArtemiaAdultIncreased BMI, hypertriglyceridemia and hepatosteatosis
    Tetramin and vegetable oilJuvenile, adultIncreased weight gain, cardiovascular overload
    Artemia and egg yolk powderAdultIncreased body weight, adipose tissue mass, adipocyte hypertrophy, hyperglycemia and hepatosteatosis
    • Transgenic zebrafish obesity models
    Genetic manipulationZebrafish AgeCharacteristics
    Overexpression of agrpAll stagesIncreased linear growth, adipocyte hypertrophy
    miR-27b depletionAll stagesHyperlipidemia, hepatic steatosis and increased white adipose tissue mass
    Overexpression of akt1All stagesIncreased BMI, adipocyte hyperplasia, abnormal fat deposition, and glucose intolerance
    • Mutant zebrafish obesity models
    Genetic manipulationZebrafish AgeCharacteristics
    Mutation in trappc11LarvaeHepatomegaly and steatosis
    Mutation in cdiptLarvaeHepatic steatosis
    Mutation in gfpt1LarvaeIncreased whole body TAG and hepatic steatosis
    Mutation in vmp1LarvaeHepatic steatosis
    Mutation in achyLarvaeMitochondrial dysfunction, hepatic steatosis, and disrupted exocrine pancreas
    Mutation in slc16a6aLarvaeFasting hepatic steatosis
    Mutation in gh1Larvae, adultDecreased somatic growth, increased accumulation of adipose tissue
    cyp2r1 mutationsAdultGrowth retardation, increased adiposity
    Mutation in plxnd1AdultDisproportional SAT, altered body fat distribution after high-fat feeding, protected from insulin resistance

    The zebrafish models we provide enable rapid identification of chemical and genetic modifiers of phenotype, which serves as an attractive model system for assessing the effects of functional foods and compounds on obesity development and treatment.We also offer a range of zebrafish obesity model test systems to advance your drug candidates from discovery to IND. Contact us today to discuss your goals and how we can achieve them.

    References

    1. Zang L, et al. Zebrafish as a Model for Obesity and Diabetes. Frontiers in cell and developmental biology. 2018, 6:91.
    2. Dooley K, et al. Zebrafish: a model system for the study of human disease.Curr Opin Genet Dev. 2000, 10(3):252-6.
    3. Hasumura T, et al. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutr Metab (Lond). 2012, 9(1):73.

    For research use only. Not intended for any clinical use.

    Quick Inquiry